Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 922

Showing 1-25 of 922 citing articles:

Treatment landscape of triple-negative breast cancer — expanded options, evolving needs
Giampaolo Bianchini, Carmine De Angelis, Luca Licata, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 2, pp. 91-113
Closed Access | Times Cited: 724
Photodynamic Therapy for the Treatment and Diagnosis of Cancer–A Review of the Current Clinical Status
Gürcan Günaydın, Mustafa Emre Gedik, Seylan Ayan
Frontiers in Chemistry (2021) Vol. 9
Open Access | Times Cited: 285
Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology
Luiz G. Almeida, Hayley Thode, Yekta Eslambolchi, et al.
Pharmacological Reviews (2022) Vol. 74, Iss. 3, pp. 714-770
Open Access | Times Cited: 235
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
Kun Cheng, Ning Cai, Jinghan Zhu, et al.
Cancer Communications (2022) Vol. 42, Iss. 11, pp. 1112-1140
Open Access | Times Cited: 186
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1127-1143.e18
Open Access | Times Cited: 182
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Kyle M. Garland, Taylor L. Sheehy, John T. Wilson
Chemical Reviews (2022) Vol. 122, Iss. 6, pp. 5977-6039
Open Access | Times Cited: 180
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz, Carolina Hirsch, Tanner C. Dalton, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 720-737.e5
Open Access | Times Cited: 126
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 105
Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors
Laurel B. Darragh, Jacob Gadwa, Tiffany Pham, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 98
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review
Kin Israel Notarte, Abbygail Therese Ver, Jacqueline Veronica Velasco, et al.
Critical Reviews in Clinical Laboratory Sciences (2022) Vol. 59, Iss. 6, pp. 373-390
Open Access | Times Cited: 88
Engineering interferons and interleukins for cancer immunotherapy
Patrick G. Holder, Shion A. Lim, Christine Huang, et al.
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114112-114112
Open Access | Times Cited: 87
COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes
Banafsheh Bigdelou, Mohammad Reza Sepand, Sahar Najafikhoshnoo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 83
Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
Nem Singh, Jungryun Kim, Jaewon Kim, et al.
Bioactive Materials (2022) Vol. 21, pp. 358-380
Open Access | Times Cited: 77
Advances in single-cell RNA sequencing and its applications in cancer research
Dezhi Huang, Naya Ma, Xinlei Li, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 70
Cancer-cell-derived fumarate suppresses the anti-tumor capacity of CD8+ T cells in the tumor microenvironment
Jie Cheng, Jinxin Yan, Ying Liu, et al.
Cell Metabolism (2023) Vol. 35, Iss. 6, pp. 961-978.e10
Open Access | Times Cited: 63
Microbial metabolite butyrate promotes anti-PD-1 antitumor efficacy by modulating T cell receptor signaling of cytotoxic CD8 T cell
Xinhai Zhu, Ke Li, Guichao Liu, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 58
An acid-responsive MOF nanomedicine for augmented anti-tumor immunotherapy via a metal ion interference-mediated pyroptotic pathway
Zhenzhen Feng, Gui Chen, Min Zhong, et al.
Biomaterials (2023) Vol. 302, pp. 122333-122333
Closed Access | Times Cited: 56
Single‐Atom Nanozymes for Catalytic Therapy: Recent Advances and Challenges
Weiyi He, Jiahao Wu, Jianli Liu, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 16
Closed Access | Times Cited: 50
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 48
Innate lymphoid cells and innate-like T cells in cancer — at the crossroads of innate and adaptive immunity
Benjamin Ruf, Tim F. Greten, Firouzeh Korangy
Nature reviews. Cancer (2023) Vol. 23, Iss. 6, pp. 351-371
Closed Access | Times Cited: 44
Temperature sensitive liposome based cancer nanomedicine enables tumour lymph node immune microenvironment remodelling
Shunli Fu, Lili Chang, Shujun Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
A Review of Advanced Multifunctional Magnetic Nanostructures for Cancer Diagnosis and Therapy Integrated into an Artificial Intelligence Approach
G. Bharath, Muhammad Ashraf Sabri, Abdul Hai, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 868-868
Open Access | Times Cited: 42
Nanodrug Augmenting Antitumor Immunity for Enhanced TNBC Therapy via Pyroptosis and cGAS-STING Activation
Huihai Zhong, Gengjia Chen, Tan Li, et al.
Nano Letters (2023) Vol. 23, Iss. 11, pp. 5083-5091
Closed Access | Times Cited: 41
DNA framework signal amplification platform-based high-throughput systemic immune monitoring
Ye Chen, Xingyu Chen, Bowen Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 41
Current advances in metal–organic frameworks for cancer nanodynamic therapies
Zhu Liu, Ziwei Yan, Yifan Di, et al.
Coordination Chemistry Reviews (2023) Vol. 497, pp. 215434-215434
Closed Access | Times Cited: 40
Page 1 - Next Page

Scroll to top